Want to join the conversation?
$CCL $CUK said it was notified on April 4 that Board member Richard Glasier exercised options on April 1 to buy 10,000 shares of $CCL common stock at $47.83 per share. The options were scheduled to expire on Oct. 16. Upon exercise, Glasier sold all 10,000 Shares on the NYSE at an average sale price of $52.43 per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?